EUVIMEDEUVIMED entdecken
Open Access

Prevalence and Predictors of Barrett’s Esophagus After Negative Initial Endoscopy: Analysis From Two National Databases

Lovekirat Dhaliwal, Amrit K Kamboj, J Lucas Williams, Apoorva K Chandar, Karan Sachdeva, Erin Gibbons, Ramona Lansing, Melissa Passe, Jaime A Perez, Katelin L R Avenir, Scott A Martin, Cadman L Leggett und 6 weitere

Clinical Gastroenterology and Hepatology · 2024

DOI: 10.1016/j.cgh.2023.08.035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2024. Verfasst von Lovekirat Dhaliwal und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Louisiana State University Health, Shreveport, Louisiana. Hauptthemen laut MEDLINE: Barrett Esophagus, Esophageal Neoplasms, Gastroesophageal Reflux. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Guidelines suggest a single screening esophagogastroduodenoscopy (EGD) in patients with multiple risk factors for Barrett's esophagus (BE). We aimed to determine BE prevalence and predictors on repeat EGD after a negative initial EGD, using 2 large national databases (GI Quality Improvement Consortium [GIQuIC] and TriNetX). METHODS: Patients who underwent at least 2 EGDs were included and those with BE or esophageal adenocarcinoma detected at initial EGD were excluded. Patient demographics and prevalence of BE on repeat EGD were collected. Multivariate logistic regression was performed to assess for independent risk factors for BE detected on the repeat EGD. RESULTS: In 214,318 and 153,445 patients undergoing at least 2 EGDs over a median follow-up of 28-35 months, the prevalence of BE on repeat EGD was 1.7% in GIQuIC and 3.4% in TriNetX, respectively (26%-45% of baseline BE prevalence). Most (89%) patients had nondysplastic BE. The prevalence of BE remained stable over time (from 1 to >5 years from negative initial EGD) but increased with increasing number of risk factors. BE prevalence in a high-risk population (gastroesophageal reflux disease plus ≥1 risk factor for BE) was 3%-4%. CONCLUSIONS: In this study of >350,000 patients, rates of BE on repeat EGD ranged from 1.7%-3.4%, and were higher in those with multiple risk factors. Most were likely missed at initial evaluation, underscoring the importance of a high-quality initial endoscopic examination. Although routine repeat endoscopic BE screening after a negative initial examination is not recommended, repeat screening may be considered in carefully selected patients with gastroesophageal reflux disease and ≥2 risk factors for BE, potentially using nonendoscopic tools.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Barrett EsophagusEsophageal NeoplasmsGastroesophageal RefluxHumansPrevalenceEndoscopy, GastrointestinalEndoscopy, Digestive System

Stichwörter der Autor:innen

EndoscopyEsophageal adenocarcinomaScreening

Autor:innen und Institutionen

  • Department of Internal Medicine, Louisiana State University Health, Shreveport, Louisiana.
  • Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
  • GI Quality Improvement Consortium, Bethesda, Maryland.
  • Department of Internal Medicine, Case Western Reserve University Hospitals, Cleveland, Ohio.
  • Clinical Research Center, University Hospitals Cleveland Medical Center, Cleveland, Ohio.
  • Division of Gastroenterology, Case Western Reserve University Hospitals, Cleveland, Ohio.

Förderung

  • NCI NIH HHS
  • NIDDK NIH HHS
  • NCATS NIH HHS
  • Case Western Reserve University
  • National Institutes of Health

Zitieren

APA

Dhaliwal, L., Kamboj, A. K., Williams, J. L., Chandar, A. K., Sachdeva, K., Gibbons, E., Lansing, R., Passe, M., Perez, J. A., Avenir, K. L. R., Martin, S. A., Leggett, C. L., Chak, A., Falk, G. W., Wani, S., Shaheen, N. J., Kisiel, J. B., & Iyer, P. G. (2024). Prevalence and Predictors of Barrett’s Esophagus After Negative Initial Endoscopy: Analysis From Two National Databases. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2023.08.035

Vancouver

Dhaliwal L, Kamboj AK, Williams JL, Chandar AK, Sachdeva K, Gibbons E, et al. Prevalence and Predictors of Barrett’s Esophagus After Negative Initial Endoscopy: Analysis From Two National Databases. Clinical Gastroenterology and Hepatology. 2024. doi:10.1016/j.cgh.2023.08.035

BibTeX
@article{Dhaliwal2024,
  author = {Dhaliwal, Lovekirat and Kamboj, Amrit K and Williams, J Lucas and Chandar, Apoorva K and Sachdeva, Karan and Gibbons, Erin and Lansing, Ramona and Passe, Melissa and Perez, Jaime A and Avenir, Katelin L R and Martin, Scott A and Leggett, Cadman L and Chak, Amitabh and Falk, Gary W and Wani, Sachin and Shaheen, Nicholas J and Kisiel, John B and Iyer, Prasad G},
  title = {Prevalence and Predictors of Barrett’s Esophagus After Negative Initial Endoscopy: Analysis From Two National Databases},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2024},
  doi = {10.1016/j.cgh.2023.08.035}
}
Kostenlos starten →